CONTEXTVISION AB (CONTX.OL) Fundamental Analysis & Valuation

OSL:CONTX • SE0014731154

3.09 NOK
0 (0%)
Last: Mar 12, 2026, 10:32 AM

This CONTX.OL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

Overall CONTX gets a fundamental rating of 5 out of 10. We evaluated CONTX against 12 industry peers in the Health Care Technology industry. Both the profitability and the financial health of CONTX get a neutral evaluation. Nothing too spectacular is happening here. CONTX is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. CONTX.OL Profitability Analysis

1.1 Basic Checks

  • CONTX had positive earnings in the past year.
  • In the past year CONTX had a positive cash flow from operations.
  • Of the past 5 years CONTX 4 years were profitable.
  • In the past 5 years CONTX always reported a positive cash flow from operatings.
CONTX.OL Yearly Net Income VS EBIT VS OCF VS FCFCONTX.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M 20M 30M 40M

1.2 Ratios

  • CONTX has a Return On Assets (0.61%) which is comparable to the rest of the industry.
  • Looking at the Return On Equity, with a value of 0.83%, CONTX is in line with its industry, outperforming 50.00% of the companies in the same industry.
  • With a Return On Invested Capital value of 0.30%, CONTX perfoms like the industry average, outperforming 41.67% of the companies in the same industry.
  • CONTX had an Average Return On Invested Capital over the past 3 years of 20.44%. This is significantly above the industry average of 8.30%.
  • The last Return On Invested Capital (0.30%) for CONTX is well below the 3 year average (20.44%), which needs to be investigated, but indicates that CONTX had better years and this may not be a problem.
Industry RankSector Rank
ROA 0.61%
ROE 0.83%
ROIC 0.3%
ROA(3y)16.48%
ROA(5y)14.4%
ROE(3y)23.03%
ROE(5y)18.42%
ROIC(3y)20.44%
ROIC(5y)37.45%
CONTX.OL Yearly ROA, ROE, ROICCONTX.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

1.3 Margins

  • CONTX has a Profit Margin (0.69%) which is comparable to the rest of the industry.
  • In the last couple of years the Profit Margin of CONTX has declined.
  • Looking at the Operating Margin, with a value of 0.36%, CONTX is in line with its industry, outperforming 41.67% of the companies in the same industry.
  • CONTX's Operating Margin has declined in the last couple of years.
  • CONTX's Gross Margin of 97.37% is amongst the best of the industry. CONTX outperforms 91.67% of its industry peers.
  • CONTX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 0.36%
PM (TTM) 0.69%
GM 97.37%
OM growth 3Y-77.87%
OM growth 5Y-62.43%
PM growth 3Y-69.2%
PM growth 5Y-43.82%
GM growth 3Y-1.24%
GM growth 5Y-0.07%
CONTX.OL Yearly Profit, Operating, Gross MarginsCONTX.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80 100

5

2. CONTX.OL Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CONTX is creating value.
  • CONTX has about the same amout of shares outstanding than it did 1 year ago.
  • CONTX has about the same amout of shares outstanding than it did 5 years ago.
  • CONTX has a worse debt/assets ratio than last year.
CONTX.OL Yearly Shares OutstandingCONTX.OL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
CONTX.OL Yearly Total Debt VS Total AssetsCONTX.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.2 Solvency

  • CONTX has a debt to FCF ratio of 62.32. This is a negative value and a sign of low solvency as CONTX would need 62.32 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 62.32, CONTX is in line with its industry, outperforming 41.67% of the companies in the same industry.
  • A Debt/Equity ratio of 0.10 indicates that CONTX is not too dependend on debt financing.
  • CONTX has a Debt to Equity ratio (0.10) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 62.32
Altman-Z N/A
ROIC/WACC0.04
WACC6.99%
CONTX.OL Yearly LT Debt VS Equity VS FCFCONTX.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M 80M

2.3 Liquidity

  • A Current Ratio of 4.28 indicates that CONTX has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 4.28, CONTX belongs to the top of the industry, outperforming 83.33% of the companies in the same industry.
  • CONTX has a Quick Ratio of 4.23. This indicates that CONTX is financially healthy and has no problem in meeting its short term obligations.
  • CONTX has a Quick ratio of 4.23. This is amongst the best in the industry. CONTX outperforms 83.33% of its industry peers.
Industry RankSector Rank
Current Ratio 4.28
Quick Ratio 4.23
CONTX.OL Yearly Current Assets VS Current LiabilitesCONTX.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

4

3. CONTX.OL Growth Analysis

3.1 Past

  • The earnings per share for CONTX have decreased strongly by -96.77% in the last year.
  • The earnings per share for CONTX have been decreasing by -41.36% on average. This is quite bad
  • Looking at the last year, CONTX shows a very negative growth in Revenue. The Revenue has decreased by -15.61% in the last year.
  • The Revenue has been growing slightly by 3.08% on average over the past years.
EPS 1Y (TTM)-96.77%
EPS 3Y-69.6%
EPS 5Y-41.36%
EPS Q2Q%-42.87%
Revenue 1Y (TTM)-15.61%
Revenue growth 3Y-2.18%
Revenue growth 5Y3.08%
Sales Q2Q%-7.27%

3.2 Future

  • Based on estimates for the next years, CONTX will show a very strong growth in Earnings Per Share. The EPS will grow by 188.45% on average per year.
  • Based on estimates for the next years, CONTX will show a small growth in Revenue. The Revenue will grow by 2.70% on average per year.
EPS Next Y1100%
EPS Next 2Y324.26%
EPS Next 3Y188.45%
EPS Next 5YN/A
Revenue Next Year7.55%
Revenue Next 2Y4.61%
Revenue Next 3Y3.64%
Revenue Next 5Y2.7%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CONTX.OL Yearly Revenue VS EstimatesCONTX.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 50M 100M
CONTX.OL Yearly EPS VS EstimatesCONTX.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.1 0.2 0.3 0.4 0.5

3

4. CONTX.OL Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 309.00, CONTX can be considered very expensive at the moment.
  • Compared to the rest of the industry, the Price/Earnings ratio of CONTX is on the same level as its industry peers.
  • When comparing the Price/Earnings ratio of CONTX to the average of the S&P500 Index (26.15), we can say CONTX is valued expensively.
  • With a Price/Forward Earnings ratio of 28.61, CONTX can be considered very expensive at the moment.
  • The rest of the industry has a similar Price/Forward Earnings ratio as CONTX.
  • CONTX's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 24.27.
Industry RankSector Rank
PE 309
Fwd PE 28.61
CONTX.OL Price Earnings VS Forward Price EarningsCONTX.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300

4.2 Price Multiples

  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of CONTX indicates a slightly more expensive valuation: CONTX is more expensive than 66.67% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 1128.89
EV/EBITDA N/A
CONTX.OL Per share dataCONTX.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of CONTX may justify a higher PE ratio.
  • A more expensive valuation may be justified as CONTX's earnings are expected to grow with 188.45% in the coming years.
PEG (NY)0.28
PEG (5Y)N/A
EPS Next 2Y324.26%
EPS Next 3Y188.45%

6

5. CONTX.OL Dividend Analysis

5.1 Amount

  • CONTX has a Yearly Dividend Yield of 4.18%, which is a nice return.
  • The stock price of CONTX dropped by -22.56% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
  • CONTX's Dividend Yield is rather good when compared to the industry average which is at 2.10. CONTX pays more dividend than 83.33% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, CONTX pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.18%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DP0%
EPS Next 2Y324.26%
EPS Next 3Y188.45%
CONTX.OL Yearly Income VS Free CF VS DividendCONTX.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M 20M 30M

CONTX.OL Fundamentals: All Metrics, Ratios and Statistics

CONTEXTVISION AB

OSL:CONTX (3/12/2026, 10:32:35 AM)

3.09

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)02-19
Earnings (Next)05-08
Inst Owners6.92%
Inst Owner ChangeN/A
Ins Owners24%
Ins Owner ChangeN/A
Market Cap239.07M
Revenue(TTM)110.28M
Net Income(TTM)762.00K
Analysts40
Price Target4.08 (32.04%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.18%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-9.09%
EPS NY rev (3m)-9.09%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)1.79%
Revenue NY rev (3m)1.79%
Valuation
Industry RankSector Rank
PE 309
Fwd PE 28.61
P/S 2.07
P/FCF 1128.89
P/OCF 51.35
P/B 2.47
P/tB 2.54
EV/EBITDA N/A
EPS(TTM)0.01
EY0.32%
EPS(NY)0.11
Fwd EY3.49%
FCF(TTM)0
FCFY0.09%
OCF(TTM)0.06
OCFY1.95%
SpS1.49
BVpS1.25
TBVpS1.22
PEG (NY)0.28
PEG (5Y)N/A
Graham Number0.53
Profitability
Industry RankSector Rank
ROA 0.61%
ROE 0.83%
ROCE 0.39%
ROIC 0.3%
ROICexc 0.96%
ROICexgc 1.03%
OM 0.36%
PM (TTM) 0.69%
GM 97.37%
FCFM 0.18%
ROA(3y)16.48%
ROA(5y)14.4%
ROE(3y)23.03%
ROE(5y)18.42%
ROIC(3y)20.44%
ROIC(5y)37.45%
ROICexc(3y)77.73%
ROICexc(5y)111.49%
ROICexgc(3y)103.93%
ROICexgc(5y)184.88%
ROCE(3y)26.61%
ROCE(5y)48.75%
ROICexgc growth 3Y-81.88%
ROICexgc growth 5Y-66.49%
ROICexc growth 3Y-79.52%
ROICexc growth 5Y-59.81%
OM growth 3Y-77.87%
OM growth 5Y-62.43%
PM growth 3Y-69.2%
PM growth 5Y-43.82%
GM growth 3Y-1.24%
GM growth 5Y-0.07%
F-Score5
Asset Turnover0.88
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 62.32
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 3.84%
Interest Coverage 0.99
Cash Conversion N/A
Profit Quality 26.51%
Current Ratio 4.28
Quick Ratio 4.23
Altman-Z N/A
F-Score5
WACC6.99%
ROIC/WACC0.04
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)3.73%
Cap/Sales(5y)4.01%
Profit Quality(3y)87.57%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-96.77%
EPS 3Y-69.6%
EPS 5Y-41.36%
EPS Q2Q%-42.87%
EPS Next Y1100%
EPS Next 2Y324.26%
EPS Next 3Y188.45%
EPS Next 5YN/A
Revenue 1Y (TTM)-15.61%
Revenue growth 3Y-2.18%
Revenue growth 5Y3.08%
Sales Q2Q%-7.27%
Revenue Next Year7.55%
Revenue Next 2Y4.61%
Revenue Next 3Y3.64%
Revenue Next 5Y2.7%
EBIT growth 1Y-98.68%
EBIT growth 3Y-78.36%
EBIT growth 5Y-61.27%
EBIT Next Year2775%
EBIT Next 3Y208.99%
EBIT Next 5YN/A
FCF growth 1Y-99.31%
FCF growth 3Y-78.75%
FCF growth 5Y-57.02%
OCF growth 1Y-86.52%
OCF growth 3Y-44.44%
OCF growth 5Y-27.59%

CONTEXTVISION AB / CONTX.OL FAQ

What is the ChartMill fundamental rating of CONTEXTVISION AB (CONTX.OL) stock?

ChartMill assigns a fundamental rating of 5 / 10 to CONTX.OL.


What is the valuation status for CONTX stock?

ChartMill assigns a valuation rating of 3 / 10 to CONTEXTVISION AB (CONTX.OL). This can be considered as Overvalued.


What is the profitability of CONTX stock?

CONTEXTVISION AB (CONTX.OL) has a profitability rating of 6 / 10.


What is the financial health of CONTEXTVISION AB (CONTX.OL) stock?

The financial health rating of CONTEXTVISION AB (CONTX.OL) is 5 / 10.


What is the expected EPS growth for CONTEXTVISION AB (CONTX.OL) stock?

The Earnings per Share (EPS) of CONTEXTVISION AB (CONTX.OL) is expected to grow by 1100% in the next year.